Materials Healthcare Sector

Corcept Therapeutics

Market Cap: US$8.4b

Engages in discovery and development of medication for the treatment of severe endocrinologic, oncologic, metabolic, and neurologic disorders in the United States.

Cytokinetics

Market Cap: US$8.3b

A late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases in the United States.

Avantor

Market Cap: US$8.0b

Engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa.

Nuvalent

Market Cap: US$7.9b

A clinical-stage biopharmaceutical company, engages in the development of therapies for patients with cancer.

Arrowhead Pharmaceuticals

Market Cap: US$7.8b

Develops medicines for the treatment of intractable diseases in the United States.

Masimo

Market Cap: US$7.7b

Develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide.

Molina Healthcare

Market Cap: US$7.6b

Provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces.

Axsome Therapeutics

Market Cap: US$7.6b

A biopharmaceutical company, develops and delivers novel therapies for the management of central nervous system (CNS) disorders in the United States.

BrightSpring Health Services

Market Cap: US$7.5b

Operates as a home and community-based healthcare services platform in the United States.

Sonic Healthcare

Market Cap: AU$11.5b

Offers medical diagnostic services, and administrative services and facilities to medical practitioners in Australia, the United States, Germany, and internationally.

Bruker

Market Cap: US$7.4b

Develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally.

Merus

Market Cap: US$7.3b

A clinical-stage immuno-oncology company, engages in the development of antibody therapeutics in the Netherlands.

Rhythm Pharmaceuticals

Market Cap: US$7.2b

A commercial-stage biopharmaceutical company, focuses on the rare neuroendocrine diseases.

Waystar Holding

Market Cap: US$7.1b

Develops a cloud-based software solution for healthcare payments.

Caris Life Sciences

Market Cap: US$7.1b

An artificial intelligence TechBio company, provides molecular profiling services in the United States and internationally.

PTC Therapeutics

Market Cap: US$6.9b

A biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to children and adults living with rare disorders in the United States and internationally.

Cidara Therapeutics

Market Cap: US$6.9b

Operates as a biotechnology company that focuses on developing targeted therapies for patients facing cancers and other serious diseases.

Vaxcyte

Market Cap: US$6.5b

A clinical-stage vaccine innovation company, develops conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases.

RadNet

Market Cap: US$6.4b

Provides outpatient diagnostic imaging services in the United States and internationally.

Krystal Biotech

Market Cap: US$6.3b

A commercial-stage biotechnology company, discovers, develops, manufactures, and commercializes genetic medicines to treat diseases with high unmet medical needs in the United States.

Stevanato Group

Market Cap: US$6.3b

Engages in the design, production, and distribution of products and processes to provide solutions for biopharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific.

Chemed

Market Cap: US$6.2b

Provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States.

Cogent Biosciences

Market Cap: US$6.1b

A biotechnology company, focuses on developing precision therapies for genetically defined diseases.

Convatec Group

Market Cap: UK£4.6b

Engages in the development, manufacturing, and sale of medical products, services and technologies in Europe, North America, and internationally.

Glaukos

Market Cap: US$6.1b

An ophthalmic pharmaceutical and medical technology company, develops therapies for the treatment of glaucoma, corneal disorders, and retinal diseases in the United States and internationally.

iRhythm Technologies

Market Cap: US$6.0b

A digital healthcare company, engages in the design, development, and commercialization of device-based technology that provides ambulatory cardiac monitoring services to diagnose arrhythmias in the United States.

BillionToOne

Market Cap: US$5.8b

A precision diagnostics company, quantifies biology to create molecular diagnostics.

Bausch + Lomb

Market Cap: US$5.7b

Operates as an eye health company in the United States, Puerto Rico, China, France, Japan, Germany, the United Kingdom, Canada, Russia, Spain, Italy, Mexico, Poland, and internationally.

Protagonist Therapeutics

Market Cap: US$5.6b

A biopharmaceutical company, develops peptide therapeutics for hematology and blood disorders, and inflammatory and immunomodulatory diseases.

Regencell Bioscience Holdings

Market Cap: US$5.5b

Operates as a Traditional Chinese medicine (TCM) bioscience company in Hong Kong.

Ramsay Health Care

Market Cap: AU$8.3b

Owns and operates hospitals in Australia and internationally.

Merit Medical Systems

Market Cap: US$5.2b

Designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States and internationally.

Teleflex

Market Cap: US$5.1b

Designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide.

CRISPR Therapeutics

Market Cap: US$5.1b

A gene editing company, focuses on developing gene-based medicines for serious human diseases using its Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform.

Legend Biotech

Market Cap: US$5.1b

Through its subsidiaries, operates as a biopharmaceutical company that discovers, develops, manufactures, and commercializes novel cell therapies for oncology and other indications in the United States, China, and Europe.

PACS Group

Market Cap: US$5.0b

Through its subsidiaries, operates skilled nursing facilities and assisted living facilities in the United States.